IP Library Granted Patent US 9,387,148
Granted Patent B2
US 9,387,148 · App. 12/578,214 · Granted Jul 12, 2016

Dosage form package and a frangible electrical circuit sheet therefor

Inventors: Ronald Rosenbaum (Palm Harbor, FL); Vincent G. D'Agostino (Walpole, MA); Robert J. Depke (Orland Park, IL)
Assignee: MTS Medication Technologies, Inc.
A61J1/035H05K1/0286A61J7/0481A61J2007/0436A61J2200/30H05K1/0293H05K1/167H05K3/005H05K2203/162H05K2203/175
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,387,148
App. No.
12/578,214
Granted
Jul 12, 2016
Kind
B2
Abstract

A frangible electrical circuit sheet for a dosage form package includes a first plurality of electrically conductive trace subnetworks interconnected with one another to form a network of electrically conductive traces and disposed on the sheet. The sheet further includes a second plurality of circuit elements connected to the network of electrically conductive traces such that each circuit element is associated with one of the subnetworks. At least some of the circuit elements have element values that differ from one another.

Claims (31)

1. A product package having a frangible electrical circuit and a plurality of individual package cavities, comprising:

the individual package cavities arranged in rows or columns;

wherein each individual package cavity has a unique corresponding plurality of electrical paths and at least one circuit element, the at least one circuit element being located in one of the electrical paths and having a predetermined measurable electrical characteristic that facilitates automated identification of whether the corresponding cavity has been opened;

wherein each individual package cavity has a corresponding frangible electrical circuit that is broken when the individual package cavity is opened, the broken portion eliminating one of the plurality of electrical paths associated with the individual package cavity; and

further comprising one detection circuit for each row or column of individual package cavities connecting the electrical paths associated with every individual package cavity in the row or column of the package such that one or more electrical parameters corresponding to the detection circuit determines which individual package cavities of the row or column have been opened and further wherein a predetermined value for at least one electrical parameter is associated with each of every possible combination of opened cavities for each row or column.

2. The package of claim 1 , wherein each circuit element comprises a resistive element.

3. The package of claim 2 , wherein the resistive element associated with each individual package cavity in each row or column differ from one another by powers of two.

4. A solid pharmaceutical blister package, comprising:

a sheet of material defining a first plurality of cavities; and

a frangible electrical circuit sheet disposed adjacent the sheet of material such that the first plurality of cavities are fully enclosed at least in part by the circuit sheet:

the plurality of individual package cavities arranged in rows or columns;

wherein each individual package cavity has a unique corresponding plurality of electrical paths and at least one circuit element, the at least one circuit element being located in one of the electrical paths and having a predetermined measurable electrical characteristic that facilitates automated identification of whether the corresponding cavity has been opened;

wherein each individual package cavity has a corresponding frangible electrical circuit that is broken when the individual package cavity is opened, the broken portion eliminating one of the plurality of electrical paths associated with the individual package cavity; and

further comprising one detection circuit for each row or column of individual package cavities connecting the electrical paths associated with every individual package cavity in the row or column of the package such that one or more electrical parameters corresponding to the detection circuit determines which individual package cavities of the row or column have been opened and further wherein a predetermined value for at least one electrical parameter is associated with each of every possible combination of opened cavities for each row or column.

5. The blister package of claim 4 , further comprising solid pharmaceuticals stored in the cavities.

6. The blister package of claim 4 , further comprising a programmed computer coupled to a connector, wherein the computer includes means for identifying which individual package cavities have been opened.

7. The blister package of claim 6 , wherein the computer further includes means for updating a database.

8. The blister package of claim 6 , wherein the connector includes a transceiver that communicates information wirelessly.

9. The blister package of claim 4 , wherein each circuit element comprises a resistive element.

10. The blister package of claim 4 , wherein each circuit element comprises a resistive element having a resistance value that is dependent upon its position within the package.

11. The blister package of claim 10 , wherein the circuit elements for each row or column have resistive values that differ from one another by powers of two.

12. The blister package of claim 11 , wherein the circuit elements of one of the rows have resistive values that are identical to the resistive values of the resistive elements associated with another of the rows.

13. A package having a plurality of cavities, comprising:

a plurality of individual package cavities arranged in rows or columns;

wherein each individual package cavity has a unique corresponding plurality of electrical paths and at least one circuit element, the at least one circuit element being located in one of the electrical paths and having a predetermined measurable electrical characteristic that facilitates automated identification of whether the corresponding cavity has been opened;

wherein each individual package cavity has a corresponding frangible electrical circuit that is broken when the individual package cavity is opened, the broken portion eliminating one of the plurality of electrical paths associated with the individual package cavity; and

further comprising one detection circuit for each row or column of individual package cavities connecting the electrical paths associated with every individual package cavity in the row or column of the package such that one or more electrical parameters corresponding to the detection circuit determines which individual package cavities of the row or column have been opened and further wherein a predetermined value for at least one electrical parameter is associated with each of every possible combination of opened cavities for each row or column.

14. The package of claim 13 , further comprising a solid pharmaceutical product stored in one of the cavities.

15. The package of claim 14 , further comprising a connector for connecting the package.

16. The package of claim 13 , wherein each circuit element comprises a resistive element.

17. The package of claim 16 , wherein the circuit elements of each row or column of the package have resistive values that differ from one another by powers of two.

Assignments (6)
SECURITY INTEREST Recorded Jan 7, 2016
From: MTS MEDICATION TECHNOLOGIES, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 037434/0818 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2016
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: MTS MEDICATION TECHNOLOGIES, INC.
Reel/Frame 037424/0971 →
SECURITY AGREEMENT Recorded Sep 27, 2013
From: MTS MEDICATION TECHNOLOGIES, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 031301/0958 →
RELEASE OF SECURITY INTEREST Recorded May 25, 2012
From: GCI CAPITAL MARKETS LLC
To: MTS MEDICATIONS TECHNOLOGIES, INC.
Reel/Frame 028272/0563 →
SECURITY AGREEMENT Recorded Jun 17, 2011
From: MTS MEDICATION TECHNOLOGIES, INC.
To: GCI CAPITAL MARKETS LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 026464/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2009
From: ROSENBAUM, RONALD; D'AUGUSTINO, VINCENT G.; DEPKE, ROBERT J.
To: MTS MEDICATION TECHNOLOGIES, INC.
Reel/Frame 023365/0615 →
Continuity (2)
Continuation In Part 12288003 · Oct 14, 2008
Related Publication 20100089791A1 · Apr 15, 2010